Literature DB >> 29305554

ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis.

Donald R Branch1,2,3, Åsa Hellberg4,5, Christine W Bruggeman6, Jill R Storry4,5, Darinka Sakac3, Megan Blacquiere3, Tik Nga Tong2,3, Emeralda Burke-Murphy3, Beth Binnington3, Nagina Parmar7, Lorna Sampson Riden7, Kezia Willie7, Chantal Armali8, Jiwajee Aziz9, Lani Lieberman2,7, Vincent Laroche10, Jeannie Callum2,8, Yulia Lin2,8, Nadine Shehata2,11,12, Katerina Pavenski2,9, Wendy Lau2,11,13, Barbara Hannach12, Taco W Kuijpers6,14, Martin L Olsson4,5, Christine Cserti-Gazdewich1,2,7,12, Jacob Pendergrast1,2,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29305554     DOI： 10.1182/blood-2017-07-796151

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products.

Authors:  Christine W Bruggeman; Sietse Q Nagelkerke; Wendy Lau; Cedric Manlhiot; Masja de Haas; Robin van Bruggen; Brian W McCrindle; Rae S M Yeung; Taco W Kuijpers
Journal:  Blood Adv       Date:  2020-07-28

2.  Anti-JMH alloantibody in inherited JMH-negative patients leads to immunogenic destruction of JMH-positive RBCs.

Authors:  Zhaohu Yuan; Yaming Wei; Xiaojie Chen; Shufei He; Kui Cai; Minglu Zhong; Huiying Huang; Xinxin Tong; Zhen Liu; Xuexin Yang
Journal:  Clin Exp Immunol       Date:  2021-06-13       Impact factor: 5.732

3.  Complement activating ABO anti-A IgM/IgG act synergistically to cause erythrophagocytosis: implications among minor ABO incompatible transfusions.

Authors:  Priyanka Pandey; Waseem Q Anani; Tina Pugh; Jerome L Gottschall; Gregory A Denomme
Journal:  J Transl Med       Date:  2020-05-28       Impact factor: 5.531
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.